Stoke Therapeutics Inc (STOK) stock news · rev $184.4M
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
This STOK news page leads with what Stoke Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for STOK yet. We will not pad this page with generic market recap.
Latest reported STOK revenue for 2025-12-31 was $184.4M. Net income was -$6.9M. Revenue was up 404.5% from 2024-12-31 to 2025-12-31. STOK currently screens at market cap $1.88B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the STOK stock page; for the tape open the quote page.
STOK stock news FAQ
What are STOK's latest revenue and net income?
Latest cached Stoke Therapeutics Inc (STOK) revenue for Dec 31, 2025 was $184.4M. Net income was -$6.9M. Statements: https://lician.com/financials/stok
How did STOK revenue change from the prior cached period?
Cached Stoke Therapeutics Inc (STOK) revenue was up 404.5% from $36.6M (Dec 31, 2024) to $184.4M (Dec 31, 2025). Statements: https://lician.com/financials/stok
What is STOK's market cap?
Stoke Therapeutics Inc (STOK) market cap is $1.88B on the latest cached fundamentals snapshot.
What kind of company is STOK?
Stoke Therapeutics Inc (STOK) is a biotechnology company listed on NASDAQ.
Where is STOK stock news listed?
Cached stock news for Stoke Therapeutics Inc (STOK) is listed at https://lician.com/news/stok. Filings: https://lician.com/sec/stok
Not investment advice.